Advertisement

Topics

Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More

06:55 EDT 11 Aug 2017 | Xconomy

With President Trump holed up in New Jersey, rattling his saber at Kim Jong-un and Mitch McConnell and ignoring his own commission’s advice on the opioid crisis, there was still life sciences news from the nation’s capital. The FDA reported that generic drug approvals are set to hit a record; the agency under Commissioner Scott […]

Original Article: Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More

NEXT ARTICLE

More From BioPortfolio on "Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...